Drug Discovery Institute
Discovering dementia drugs
At Alzheimer’s Research UK, we are committed to finding treatments that slow or stop the diseases that cause dementia.
We won’t stop until we find them.
Drug Discovery Alliance: An update on progress
A highlight of the conference, in which so much was covered, was a presentation from Dr John Skidmore, Chief Scientific Officer at our Cambridge Drug Discovery Institute (DDI).
Scientist Focus: Dr John Davis
Dr John Davis is the new Chief Scientific Officer at the Alzheimer’s Research UK Oxford Drug Discovery Institute.
Scientist Focus: Prof Paul Whiting
As Chief Scientific Officer, Prof Paul Whiting will drive the progress of the Drug Discovery Institute.
Boosting the search for new dementia treatments
The Alzheimer’s Research UK Drug Discovery Alliance is a £30m powerhouse of dementia treatment discovery at leading universities for dementia research.
Drug Discovery Institute launches
Alzheimer’s Research UK launches a new initiative to bridge the gap between new knowledge about the causes of dementia and the discovery of new treatments.